Co-Authors
This is a "connection" page, showing publications co-authored by DOLORES LOPEZ-TERRADA and MILTON FINEGOLD.
Connection Strength
1.853
-
Outcomes of Patients Treated for Hepatoblastoma with Low Alpha-Fetoprotein and/or Small Cell Undifferentiated Histology: A Report from the Children's Hepatic Tumors International Collaboration (CHIC). Cancers (Basel). 2023 Jan 11; 15(2).
Score: 0.218
-
Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee. J Clin Oncol. 2022 02 10; 40(5):459-467.
Score: 0.202
-
Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the children's oncology group AHEP 0731 liver tumor committee. J Pediatr Surg. 2020 Apr; 55(4):655-659.
Score: 0.169
-
Predisposing Conditions to Pediatric Hepatocellular Carcinoma and Association With Outcomes: Single-center Experience. J Pediatr Gastroenterol Nutr. 2019 05; 68(5):695-699.
Score: 0.169
-
Characterization of pediatric hepatocellular carcinoma reveals genomic heterogeneity and diverse signaling pathway activation. Pediatr Blood Cancer. 2019 07; 66(7):e27745.
Score: 0.168
-
Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups. Hepatology. 2017 01; 65(1):104-121.
Score: 0.143
-
Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer. J Hepatol. 2016 08; 65(2):325-33.
Score: 0.137
-
Mutations of PTCH1, MLL2, and MLL3 are not frequent events in hepatoblastoma. Pediatr Blood Cancer. 2012 Jun; 58(6):1006-7.
Score: 0.101
-
Hep G2 is a hepatoblastoma-derived cell line. Hum Pathol. 2009 Oct; 40(10):1512-5.
Score: 0.087
-
Gene expression profiling reveals signatures characterizing histologic subtypes of hepatoblastoma and global deregulation in cell growth and survival pathways. Hum Pathol. 2009 Jun; 40(6):843-53.
Score: 0.083
-
Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors. Hum Pathol. 2009 Jun; 40(6):783-94.
Score: 0.083
-
Protocol for the examination of specimens from pediatric patients with hepatoblastoma. Arch Pathol Lab Med. 2007 Apr; 131(4):520-9.
Score: 0.073
-
FOXG1 is overexpressed in hepatoblastoma. Hum Pathol. 2007 Mar; 38(3):400-9.
Score: 0.072
-
Neutrophil-rich anaplastic large cell lymphoma of the skull presenting after head trauma. Pediatr Dev Pathol. 2001 Jul-Aug; 4(4):397-401.
Score: 0.049
-
Hepatoblastoma modeling in mice places Nrf2 within a cancer field established by mutant ?-catenin. JCI Insight. 2016 Oct 06; 1(16):e88549.
Score: 0.035
-
P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients. Oncotarget. 2015 Dec 01; 6(38):41162-79.
Score: 0.033
-
Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium. Mod Pathol. 2014 Mar; 27(3):472-91.
Score: 0.029